PAI
ANAC

Palo Alto Investors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Palo Alto Investors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,219,042
Closed -$119M – 46
2016
Q1 		$119M Buy
2,219,042
+31,800
+1% +$2.35M 9.21% 3
2015
Q4 		$247M Sell
2,187,242
-391,912
-15% -$43.2M 13.75% 2
2015
Q3 		$304M Sell
2,579,154
-523,873
-17% -$68.4M 14.6% 1
2015
Q2 		$240M Sell
3,103,027
-156,018
-5% -$10.2M 10.68% 2
2015
Q1 		$189M Buy
3,259,045
+737,223
+29% +$31.3M 9.32% 3
2014
Q4 		$81.3M Buy
2,521,822
+405,157
+19% +$12.2M 4.77% 9
2014
Q3 		$51.8M Buy
2,116,665
+455,053
+27% +$9.25M 3.87% 8
2014
Q2 		$29.5M Buy
1,661,612
+89,534
+6% +$1.44M 2.19% 14
2014
Q1 		$31.5M Sell
1,572,078
-31,200
-2% -$605K 2.6% 12
2013
Q4 		$26.9M Buy
1,603,278
+3,100
+0.2% +$42.9K 2.51% 13
2013
Q3 		$17M Sell
1,600,178
-17,473
-1% -$153K 1.78% 16
2013
Q2 		$9.04M Buy
+1,617,651
New +$9.79M 1.07% 19

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Palo Alto Investors's ANAC Position: Q2 2016 in Review

Palo Alto Investors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 2,219,042 shares — an estimated $119M sold.

Palo Alto Investors first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $304M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Palo Alto Investors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Palo Alto Investors sold 2,219,042 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $119M.
  • Palo Alto Investors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Palo Alto Investors's ANACOR PHARMACEUTICALS INC COM position peaked at $304M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Palo Alto Investors's 13F filing for Q2 2016, filed 15 Aug 2016.